论文部分内容阅读
目的初步了解本地区β-受体阻滞剂使用情况与指南要求差距,以进一步指导临床实践。方法制定入选患者标准,调查376例2002～2006年5年住院的心肌梗死患者中使用β-受体阻滞的资料。结果2002～2006年5个年度,心肌梗死患者β-受体阻滞剂使用率有逐年增高趋势,5年比较有统计学差别。结论随着对心肌梗死病理生理过程的认识和循证医学展示β-受体阻滞剂在心肌梗死治疗中占重要地位,其实际中应用跟指南要求的有较大差距,更加合理规范应用,仍是亟待解决的问题。
Objective To understand the difference between the use of β-blockers and guidelines in this region to further guide clinical practice. Methods The criteria for selected patients were enrolled in this study to investigate the use of β-block in 376 patients with myocardial infarction who were hospitalized for 5 years from 2002 to 2006. Results In the five years from 2002 to 2006, the utilization rate of β-blockers in patients with myocardial infarction tended to increase year by year. There was a statistically significant difference in five years. Conclusion With the understanding of the pathophysiological process of myocardial infarction and evidence-based medicine show that β-blockers play an important role in the treatment of myocardial infarction, the actual application of the method with the guidelines require a large gap between the more reasonable and standardized application, Still a problem to be solved.